J.Safra Asset Management Corp Argenx Se Transaction History
J.Safra Asset Management Corp
- $991 Million
- Q2 2024
A detailed history of J.Safra Asset Management Corp transactions in Argenx Se stock. As of the latest transaction made, J.Safra Asset Management Corp holds 69 shares of ARGX stock, worth $41,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 10
590.0%
Holding current value
$41,095
Previous $3,000
866.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
381Shares Held
31.5MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.33 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.09 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.47 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.15 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$900 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...